Cancer cell proliferation is inhibited by specific modulation frequencies

Por Zimmerman, J W, Pennison, M J, Brezovich, I, Yi, N, Yang, C T, Ramaker, R, Absher, D, Myers, R M, Kuster, N, Costa, F P, Barbault, A, Pasche, B
Publicado em 2012

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields

Por Costa, F P, de Oliveira, A C, Meirelles, R, Machado, M C C, Zanesco, T, Surjan, R, Chammas, M C, de Souza Rocha, M, Morgan, D, Cantor, A, Zimmerman, J, Brezovich, I, Kuster, N, Barbault, A, Pasche, B
Publicado em 2011

Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?

Por Yang, M, Forbes, M E, Bitting, R L, O'Neill, S S, Chou, P -C, Topaloglu, U, Miller, L D, Hawkins, G A, Grant, S C, DeYoung, B R, Petty, W J, Chen, K, Pasche, B C, Zhang, W
Publicado no Ann Oncol (2018)

Molecular analysis of SALL1 mutations in Townes-Brocks syndrome.

Por Kohlhase, J, Taschner, P E, Burfeind, P, Pasche, B, Newman, B, Blanck, C, Breuning, M H, ten Kate, L P, Maaswinkel-Mooy, P, Mitulla, B, Seidel, J, Kirkpatrick, S J, Pauli, R M, Wargowski, D S, Devriendt, K, Proesmans, W, Gabrielli, O, Coppa, G V, Wesby-van Swaay, E, Trembath, R C, Schinzel, A A, Reardon, W, Seemanova, E, Engel, W
Publicado em 1999